Stomach Injection for Weight Loss: What Does It Actually Mean?

If you have searched for “stomach injection for weight loss”, you might be wondering whether the medicine is actually injected into your stomach.

It is not.

The phrase usually refers to a prescription medicine that is injected under the skin, often in the abdomen. Depending on the medicine, the thigh or upper arm may also be used. The injection goes into the tissue beneath the skin, not into your stomach or another internal organ.

“Stomach injection”, “weight loss injection” and “slimming injection” are informal terms people use when searching for weight management treatment. They are not the names of specific medicines.

So what are these injections, how do they work, and what should you check before considering one?

This guide explains the basics in simple terms, including the difference between insulin and weight management medicines, how prescribing works in the UK, and what to know about safety.

Key things to know

• A “stomach injection” usually means a medicine injected under the skin of the abdomen. It does not go into the stomach itself.
• Depending on the medicine, injections may also be given in the thigh or upper arm.
• Some medicines that affect GLP 1 pathways are licensed for weight management in the UK. Tirzepatide also acts on GIP, another hormone involved in appetite and blood sugar control.
• Insulin is used to manage blood glucose in diabetes. It is not a weight management medicine.
• There is no single injection that is suitable for everyone. The choice depends on the medicine, your health, medical history and the relevant prescribing criteria.
• Prescription only medicines should be supplied after an appropriate clinical assessment.
• Side effects can happen, so it is important to understand the medicine you are prescribed and know when to seek medical advice.
• Buying weight loss medicines from unregulated websites or social media sellers can put your health at risk.

What does “stomach injection” actually mean?

The wording can make the treatment sound more complicated than it is.

A “stomach injection” usually means an injection given into the fatty tissue just underneath the skin of the abdomen. This is called a subcutaneous injection.

For example, Wegovy is injected under the skin of the abdomen, thigh or upper arm. Liraglutide medicines such as Saxenda and Nevolat are also given under the skin in these areas.

The medicine does not go into your stomach, bowel or another internal organ.

Some of these medicines work through hormone pathways involved in appetite and food intake. GLP 1 medicines can help people feel fuller by acting in a similar way to a natural hormone released after eating. Tirzepatide acts on both GLP 1 and GIP pathways.

They are used alongside dietary and physical activity changes where appropriate. They are not intended to replace a balanced diet, regular movement or ongoing medical care.

What is the difference between insulin and weight management injections?

This is an easy area to get confused about, especially because both types of medicine can be given by injection.

Insulin is used to help control blood glucose in people with diabetes. It is not licensed as a weight management treatment.

Weight gain can occur with insulin treatment, although this does not happen to everyone. If you have diabetes and are concerned about your weight, do not reduce or stop insulin yourself. Changes to insulin treatment can affect your blood glucose and should be discussed with your diabetes team or prescriber.

GLP 1 medicines have a different role. Some are licensed for weight management, while others are licensed for diabetes or other uses. Whether a particular medicine can be used for weight management depends on its specific licence and the person's clinical circumstances.

If you are taking insulin and considering weight management treatment, tell your prescriber about all the medicines you use. This helps them make a safe decision about your treatment.

Which injections are licensed for weight management in the UK?

You may come across several medicine names when researching weight management treatment. They are not all the same, and their licences, dosing schedules and eligibility criteria can differ.

Semaglutide, tirzepatide and liraglutide are among the medicines used for weight management in the UK, depending on the specific product and indication.

For example, the current product information for Wegovy states that it is used for weight management in adults with a BMI of 30 kg/m² or above, or a BMI of at least 27 kg/m² but below 30 kg/m² alongside at least one weight related health condition. Mounjaro and Nevolat have their own licensed criteria.

That does not mean that everyone who meets one BMI threshold will automatically be offered every medicine. NHS treatment pathways can have additional criteria, and prescribing decisions should take the individual person into account. NICE guidance, for example, sets specific criteria for medicines used through NHS weight management pathways.

How do you start treatment?

It should begin with a conversation, not simply a product selection.

A qualified prescriber will usually need information about your weight, BMI, medical history, current medicines and any health conditions that could affect treatment. They may also ask about previous weight management attempts and other relevant factors.

The exact assessment depends on the medicine and the service providing care.

For example, the licensed indication for Mounjaro includes adults with a BMI of 30 kg/m² or above, or adults with a BMI of at least 27 kg/m² but below 30 kg/m² who also have at least one weight related health condition.

Nevolat has a similar licensed BMI range for adults, with treatment indicated alongside a reduced calorie diet and increased physical activity.

However, a BMI number on its own does not tell the whole story. Your other medicines, medical history and existing health conditions may also matter.

Can treatment be started online?

Sometimes, yes. Some UK services offer remote consultations rather than face to face appointments.

The important part is what happens during that consultation.

A proper prescribing service should gather enough information to assess whether treatment is appropriate rather than simply asking you to choose a medicine and pay for it. You should also be able to find clear information about who is prescribing, how the medicine is supplied and what support is available if you have questions or side effects.

If you prefer face to face care, you can speak with your GP, pharmacist or another suitable healthcare professional.

What should you check before choosing an online service?

Price can be useful when comparing services, but it should not be the first thing you look at.

Before ordering a prescription medicine online, check:

• whether there is a proper clinical assessment
• who is prescribing the medicine
• whether the pharmacy supplying it is appropriately registered
• whether you can get advice after treatment starts
• whether the service clearly explains how the medicine should be used
• what to do if you experience side effects

The MHRA advises people not to buy prescription weight loss medicines from unregulated websites or social media sellers. Products supplied illegally may be fake, contaminated, incorrectly dosed or contain ingredients that are not listed on the packaging.

For pharmacies in Great Britain, you can check registration through the General Pharmaceutical Council. If you are unsure about an online seller, checking the pharmacy and prescribing arrangements is more useful than relying on a low price or attractive advert.

What side effects can weight management injections cause?

It is normal to want to know how a medicine might make you feel before starting it.

GLP 1 medicines and tirzepatide can cause digestive side effects. Depending on the medicine, these may include nausea, vomiting, diarrhoea, constipation and abdominal discomfort. Reactions around the injection site can also occur. The exact side effects and how often they occur vary between medicines.

Most symptoms are not a sign of a serious problem, but some symptoms should not be ignored.

In January 2026, the MHRA strengthened warnings about the small risk of acute pancreatitis with GLP 1 medicines and dual GLP 1 and GIP receptor agonists. Severe, persistent stomach pain, particularly when it spreads to the back and may be accompanied by nausea or vomiting, needs urgent medical assessment.

Your prescriber or pharmacist should explain the side effects linked to your particular medicine and what to do if you experience them.

If something does not feel right, it is better to ask than to guess.

What about weight loss results?

It is understandable to want to know how much weight you might lose before starting treatment.

Clinical studies show that some weight management medicines can lead to weight loss when used as part of an appropriate treatment plan. However, study results describe what happened in a group of people under specific trial conditions. They cannot tell you exactly how much weight you personally will lose.

Your response can depend on the medicine, dose, length of treatment, health conditions and how your body responds.

This is also why promises of a fixed amount of weight loss or very rapid results should be treated carefully. The MHRA has specifically advised people to be cautious about weight loss products promoted as “quick fixes” or “miracle results”.

Do these injections specifically target stomach fat?

No. The fact that an injection may be given in the abdomen does not mean that it targets fat around your stomach.

The injection site is simply where the medicine is administered under the skin. The medicine works through its intended biological pathways rather than directly breaking down fat at the injection site.

So, if you inject a weight management medicine into your abdomen, it does not mean that the medicine is specifically targeting belly fat.

Changes in body weight and body fat can happen differently from person to person.

What if you have another health condition?

This is one of the reasons a proper medical assessment matters.

If you have diabetes, high blood pressure, heart disease, sleep apnoea or another ongoing health condition, tell your prescriber. Your other medicines are important too.

For example, people taking insulin should not change their insulin dose simply because they are starting or considering a weight management medicine. Your diabetes team can help you manage both your blood glucose and weight safely.

NICE also recommends that medicines for weight management are prescribed alongside support around diet, physical activity and behaviour change where appropriate.

You do not need to work everything out on your own. Your healthcare professional can explain how a medicine fits into your wider treatment plan.

Medical Disclaimer

This content is for general information only. It is not a substitute for medical advice, diagnosis or treatment.

Prescription weight management medicines are not suitable for everyone. A qualified prescriber should consider your health, medical history, current medicines and the specific medicine being considered before treatment is prescribed.

Results and side effects can vary between individuals. If you are unsure whether a medicine is suitable for you, speak with a GP, pharmacist or another qualified healthcare professional.